Cargando…

KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway

BACKGROUND: Non-small cell lung cancer (NSCLC) is a major histological subtype of lung cancer with high mortality and morbidity. A substantial amount of evidence demonstrates long non-coding RNAs (lncRNA) as critical regulators in tumorigeneis and malignant progression of human cancers. The oncogeni...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Jiang, Yang, Chao, An, Jinlu, Hao, Dexun, Liu, Cong, Liu, Jumin, Sun, Jing, Jiang, Junguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086369/
https://www.ncbi.nlm.nih.gov/pubmed/33931086
http://dx.doi.org/10.1186/s13046-021-01943-5
_version_ 1783686508621856768
author Shi, Jiang
Yang, Chao
An, Jinlu
Hao, Dexun
Liu, Cong
Liu, Jumin
Sun, Jing
Jiang, Junguang
author_facet Shi, Jiang
Yang, Chao
An, Jinlu
Hao, Dexun
Liu, Cong
Liu, Jumin
Sun, Jing
Jiang, Junguang
author_sort Shi, Jiang
collection PubMed
description BACKGROUND: Non-small cell lung cancer (NSCLC) is a major histological subtype of lung cancer with high mortality and morbidity. A substantial amount of evidence demonstrates long non-coding RNAs (lncRNA) as critical regulators in tumorigeneis and malignant progression of human cancers. The oncogenic role of BBOX1 anti-sense RNA 1 (BBOX1-AS1) has been reported in several tumors. As yet, the potential functions and mechanisms of BBOX1-AS1 in NSCLC are obscure. METHODS: The gene and protein expression was detected by qRT-PCR and western blot. Cell function was determined by CCK-8, colony forming, would healing and transwell assays. Bioinformatics tools, ChIP assays, dual luciferase reporters system and RNA pull-down experiments were used to examine the interaction between molecules. Subcutaneous tumor models in nude mice were established to investigate in vivo NSCLC cell behavior. RESULTS: BBOX1-AS1 was highly expressed in NSCLC tissues and cells. High BBOX1-AS1 expression was associated with worse clinical parameters and poor prognosis. BBOX1-AS1 up-regulation was induced by transcription factor KLF5. BBOX1-AS1 deficiency resulted in an inhibition of cell proliferation, migration, invasion and EMT in vitro. Also, knockdown of BBOX1-AS1 suppressed NSCLC xenograft tumor growth in mice in vivo. Mechanistically, BBOX1-AS1 acted act as a competetive “sponge” of miR-27a-5p to promote maternal embryonic leucine zipper kinase (MELK) expression and activate FAK signaling. miR-27a-5p was confirmed as a tumor suppressor in NSCLC. Moreover, BBOX1-AS1-induced increase of cell proliferation, migration, invasion and EMT was greatly reversed due to the overexpression of miR-27a-5p. In addition, the suppressive effect of NSCLC progression owing to BBOX1-AS1 depletion was abated by the up-regulation of MELK. Consistently, BBOX1-AS1-mediated carcinogenicity was attenuated in NSCLC after treatment with a specific MELK inhibitor OTSSP167. CONCLUSIONS: KLF5-induced BBOX1-AS1 exerts tumor-promotive roles in NSCLC via sponging miR-27a-5p to activate MELK/FAK signaling, providing the possibility of employing BBOX1-AS1 as a therapeutic target for NSCLC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-01943-5.
format Online
Article
Text
id pubmed-8086369
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80863692021-05-03 KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway Shi, Jiang Yang, Chao An, Jinlu Hao, Dexun Liu, Cong Liu, Jumin Sun, Jing Jiang, Junguang J Exp Clin Cancer Res Research BACKGROUND: Non-small cell lung cancer (NSCLC) is a major histological subtype of lung cancer with high mortality and morbidity. A substantial amount of evidence demonstrates long non-coding RNAs (lncRNA) as critical regulators in tumorigeneis and malignant progression of human cancers. The oncogenic role of BBOX1 anti-sense RNA 1 (BBOX1-AS1) has been reported in several tumors. As yet, the potential functions and mechanisms of BBOX1-AS1 in NSCLC are obscure. METHODS: The gene and protein expression was detected by qRT-PCR and western blot. Cell function was determined by CCK-8, colony forming, would healing and transwell assays. Bioinformatics tools, ChIP assays, dual luciferase reporters system and RNA pull-down experiments were used to examine the interaction between molecules. Subcutaneous tumor models in nude mice were established to investigate in vivo NSCLC cell behavior. RESULTS: BBOX1-AS1 was highly expressed in NSCLC tissues and cells. High BBOX1-AS1 expression was associated with worse clinical parameters and poor prognosis. BBOX1-AS1 up-regulation was induced by transcription factor KLF5. BBOX1-AS1 deficiency resulted in an inhibition of cell proliferation, migration, invasion and EMT in vitro. Also, knockdown of BBOX1-AS1 suppressed NSCLC xenograft tumor growth in mice in vivo. Mechanistically, BBOX1-AS1 acted act as a competetive “sponge” of miR-27a-5p to promote maternal embryonic leucine zipper kinase (MELK) expression and activate FAK signaling. miR-27a-5p was confirmed as a tumor suppressor in NSCLC. Moreover, BBOX1-AS1-induced increase of cell proliferation, migration, invasion and EMT was greatly reversed due to the overexpression of miR-27a-5p. In addition, the suppressive effect of NSCLC progression owing to BBOX1-AS1 depletion was abated by the up-regulation of MELK. Consistently, BBOX1-AS1-mediated carcinogenicity was attenuated in NSCLC after treatment with a specific MELK inhibitor OTSSP167. CONCLUSIONS: KLF5-induced BBOX1-AS1 exerts tumor-promotive roles in NSCLC via sponging miR-27a-5p to activate MELK/FAK signaling, providing the possibility of employing BBOX1-AS1 as a therapeutic target for NSCLC patients. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-01943-5. BioMed Central 2021-04-30 /pmc/articles/PMC8086369/ /pubmed/33931086 http://dx.doi.org/10.1186/s13046-021-01943-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Shi, Jiang
Yang, Chao
An, Jinlu
Hao, Dexun
Liu, Cong
Liu, Jumin
Sun, Jing
Jiang, Junguang
KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway
title KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway
title_full KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway
title_fullStr KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway
title_full_unstemmed KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway
title_short KLF5-induced BBOX1-AS1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging miR-27a-5p to up-regulate MELK and activate FAK signaling pathway
title_sort klf5-induced bbox1-as1 contributes to cell malignant phenotypes in non-small cell lung cancer via sponging mir-27a-5p to up-regulate melk and activate fak signaling pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8086369/
https://www.ncbi.nlm.nih.gov/pubmed/33931086
http://dx.doi.org/10.1186/s13046-021-01943-5
work_keys_str_mv AT shijiang klf5inducedbbox1as1contributestocellmalignantphenotypesinnonsmallcelllungcancerviaspongingmir27a5ptoupregulatemelkandactivatefaksignalingpathway
AT yangchao klf5inducedbbox1as1contributestocellmalignantphenotypesinnonsmallcelllungcancerviaspongingmir27a5ptoupregulatemelkandactivatefaksignalingpathway
AT anjinlu klf5inducedbbox1as1contributestocellmalignantphenotypesinnonsmallcelllungcancerviaspongingmir27a5ptoupregulatemelkandactivatefaksignalingpathway
AT haodexun klf5inducedbbox1as1contributestocellmalignantphenotypesinnonsmallcelllungcancerviaspongingmir27a5ptoupregulatemelkandactivatefaksignalingpathway
AT liucong klf5inducedbbox1as1contributestocellmalignantphenotypesinnonsmallcelllungcancerviaspongingmir27a5ptoupregulatemelkandactivatefaksignalingpathway
AT liujumin klf5inducedbbox1as1contributestocellmalignantphenotypesinnonsmallcelllungcancerviaspongingmir27a5ptoupregulatemelkandactivatefaksignalingpathway
AT sunjing klf5inducedbbox1as1contributestocellmalignantphenotypesinnonsmallcelllungcancerviaspongingmir27a5ptoupregulatemelkandactivatefaksignalingpathway
AT jiangjunguang klf5inducedbbox1as1contributestocellmalignantphenotypesinnonsmallcelllungcancerviaspongingmir27a5ptoupregulatemelkandactivatefaksignalingpathway